These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30027849)

  • 41. Identification of Biomarkers for Schistosoma-Associated Pulmonary Arterial Hypertension Based on RNA-Seq Data of Mouse Whole Lung Tissues.
    Sun Y; Lin X; Li L
    Lung; 2017 Jun; 195(3):377-385. PubMed ID: 28393260
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DNA Damage and Pulmonary Hypertension.
    Ranchoux B; Meloche J; Paulin R; Boucherat O; Provencher S; Bonnet S
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338373
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiovascular RNA interference therapy: the broadening tool and target spectrum.
    Poller W; Tank J; Skurk C; Gast M
    Circ Res; 2013 Aug; 113(5):588-602. PubMed ID: 23948584
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cellular interplay in pulmonary arterial hypertension: implications for new therapies.
    Nogueira-Ferreira R; Ferreira R; Henriques-Coelho T
    Biochim Biophys Acta; 2014 May; 1843(5):885-93. PubMed ID: 24491811
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical pharmacology of endothelin receptor antagonists used in the treatment of pulmonary arterial hypertension.
    Chaumais MC; Guignabert C; Savale L; Jaïs X; Boucly A; Montani D; Simonneau G; Humbert M; Sitbon O
    Am J Cardiovasc Drugs; 2015 Feb; 15(1):13-26. PubMed ID: 25421754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of pulmonary arterial hypertension in children.
    Roofthooft MT; van Loon RL; Berger RM
    Paediatr Respir Rev; 2010 Dec; 11(4):240-5. PubMed ID: 21109183
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Current research advances of the relationship between non-coding RNAs and tumor].
    Li K; Guo J; Xiao B; Zhou H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):56-9. PubMed ID: 20140869
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of noncoding RNA in vascular remodelling.
    Deng L; Bradshaw AC; Baker AH
    Curr Opin Lipidol; 2016 Oct; 27(5):439-48. PubMed ID: 27472407
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pulmonary arterial hypertension: new insights and new hope.
    Martin KB; Klinger JR; Rounds SI
    Respirology; 2006 Jan; 11(1):6-17. PubMed ID: 16423196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Salidroside attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2a receptor related mitochondria-dependent apoptosis pathway.
    Huang X; Zou L; Yu X; Chen M; Guo R; Cai H; Yao D; Xu X; Chen Y; Ding C; Cai X; Wang L
    J Mol Cell Cardiol; 2015 May; 82():153-66. PubMed ID: 25772255
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury.
    Viereck J; Thum T
    Circ Res; 2017 Jan; 120(2):381-399. PubMed ID: 28104771
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cocktail of Superoxide Dismutase and Fasudil Encapsulated in Targeted Liposomes Slows PAH Progression at a Reduced Dosing Frequency.
    Gupta N; Rashid J; Nozik-Grayck E; McMurtry IF; Stenmark KR; Ahsan F
    Mol Pharm; 2017 Mar; 14(3):830-841. PubMed ID: 28165252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Moderate pulmonary arterial hypertension in male mice lacking the vasoactive intestinal peptide gene.
    Said SI; Hamidi SA; Dickman KG; Szema AM; Lyubsky S; Lin RZ; Jiang YP; Chen JJ; Waschek JA; Kort S
    Circulation; 2007 Mar; 115(10):1260-8. PubMed ID: 17309917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Current recommendations on diagnosis and treatment of pulmonary arterial hypertension].
    Ter Arkh; 2012; 84(4):57-63. PubMed ID: 22774493
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.
    Xie SS; Jin J; Xu X; Zhuo W; Zhou TH
    World J Gastroenterol; 2016 Jan; 22(3):1213-23. PubMed ID: 26811659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Global identification of noncoding RNAs in Saccharomyces cerevisiae by modulating an essential RNA processing pathway.
    Samanta MP; Tongprasit W; Sethi H; Chin CS; Stolc V
    Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4192-7. PubMed ID: 16537507
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Research progress of non-coding RNA in pulmonary hypertension].
    Su H; Chen EG; Wu XH; Ying KJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2021 Feb; 44(2):136-142. PubMed ID: 33535329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Non‑coding RNAs and ovarian diseases (Review).
    Li D; Xu D; Zou Y; Xu Y; Fu L; Xu X; Liu Y; Zhang X; Zhang J; Ming H; Zheng L
    Mol Med Rep; 2017 Apr; 15(4):1435-1440. PubMed ID: 28259997
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The metabolic theory of pulmonary arterial hypertension.
    Paulin R; Michelakis ED
    Circ Res; 2014 Jun; 115(1):148-64. PubMed ID: 24951764
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extracellular Vesicle-Mediated Vascular Cell Communications in Hypertension: Mechanism Insights and Therapeutic Potential of ncRNAs.
    Zhang JR; Sun HJ
    Cardiovasc Drugs Ther; 2022 Feb; 36(1):157-172. PubMed ID: 32964302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.